Akèy › Amiloidoz Chèn Limyè Imunoglobulin › Ohio
Etid klinik pou Amiloidoz Chèn Limyè Imunoglobulin nan Ohio
5 etid pou Amiloidoz Chèn Limyè Imunoglobulin ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
- Cleaveland Clinic, Cleveland
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT06569147A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Cleveland
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 2, 2026 · NCT07081646Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- Case Western Reserve University, Cleveland
- Riverside Methodist Hospital, Columbus
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT06022939Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
- Ohio State University Medical Center, Columbus
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 23, 2026 · NCT01408225Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- The Ohio State University Comprehensive Cancer Center, Columbus
Ap rekriteEtid obsèvasyon
Laj 40 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT06365060Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.